Novartis sells joint venture stake to GSK for $13 billion
Swiss pharmaceutical firm Novartis is selling its stake in a consumer health care joint venture with GlaxoSmithKline to the British company for $13 billion. The joint venture was formed in 2015 and Novartis holds a 36.5-percent stake.
from Biotech News
0 Comments